| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hippocampus | 16 | 2026 | 277 | 4.910 |
Why?
|
| Amyotrophic Lateral Sclerosis | 17 | 2025 | 517 | 4.590 |
Why?
|
| Epigenesis, Genetic | 15 | 2026 | 408 | 4.000 |
Why?
|
| Frontotemporal Dementia | 6 | 2025 | 158 | 2.370 |
Why?
|
| Memory | 5 | 2026 | 124 | 2.370 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 9 | 2022 | 90 | 2.320 |
Why?
|
| Alzheimer Disease | 6 | 2025 | 773 | 2.270 |
Why?
|
| Motor Neurons | 8 | 2025 | 219 | 2.120 |
Why?
|
| Astrocytes | 10 | 2025 | 123 | 2.000 |
Why?
|
| Disks Large Homolog 4 Protein | 7 | 2025 | 21 | 1.930 |
Why?
|
| Dendrites | 6 | 2019 | 60 | 1.860 |
Why?
|
| Neurons | 19 | 2026 | 935 | 1.780 |
Why?
|
| Superoxide Dismutase-1 | 8 | 2025 | 148 | 1.780 |
Why?
|
| Neurogenesis | 5 | 2019 | 64 | 1.770 |
Why?
|
| Mice, Transgenic | 14 | 2026 | 1292 | 1.610 |
Why?
|
| Histones | 10 | 2026 | 497 | 1.530 |
Why?
|
| Neurodegenerative Diseases | 3 | 2025 | 152 | 1.400 |
Why?
|
| Animals | 56 | 2026 | 21492 | 1.360 |
Why?
|
| C9orf72 Protein | 3 | 2022 | 115 | 1.360 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2018 | 345 | 1.230 |
Why?
|
| Neuronal Plasticity | 9 | 2025 | 155 | 1.180 |
Why?
|
| DNA Methylation | 4 | 2025 | 307 | 1.100 |
Why?
|
| Air Pollutants | 3 | 2025 | 100 | 1.080 |
Why?
|
| Mice | 31 | 2026 | 11185 | 1.070 |
Why?
|
| Air Pollution | 2 | 2025 | 42 | 1.030 |
Why?
|
| Rats | 19 | 2025 | 2005 | 1.020 |
Why?
|
| Membrane Proteins | 5 | 2016 | 926 | 1.010 |
Why?
|
| ras-GRF1 | 2 | 2019 | 3 | 0.910 |
Why?
|
| Synapses | 6 | 2013 | 195 | 0.860 |
Why?
|
| Axonal Transport | 1 | 2024 | 32 | 0.850 |
Why?
|
| Rats, Sprague-Dawley | 12 | 2025 | 626 | 0.840 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2024 | 98 | 0.810 |
Why?
|
| Superoxide Dismutase | 5 | 2017 | 223 | 0.800 |
Why?
|
| Huntington Disease | 1 | 2025 | 164 | 0.790 |
Why?
|
| Learning | 1 | 2025 | 186 | 0.770 |
Why?
|
| Parkinson Disease | 1 | 2024 | 135 | 0.730 |
Why?
|
| Receptors, Glycine | 6 | 2007 | 9 | 0.720 |
Why?
|
| Disease Models, Animal | 12 | 2025 | 2329 | 0.720 |
Why?
|
| Connexins | 2 | 2021 | 9 | 0.700 |
Why?
|
| Spinal Cord | 8 | 2025 | 210 | 0.700 |
Why?
|
| Cells, Cultured | 15 | 2025 | 2194 | 0.680 |
Why?
|
| Osteoblasts | 6 | 2020 | 204 | 0.680 |
Why?
|
| Histone Acetyltransferases | 1 | 2021 | 59 | 0.660 |
Why?
|
| Mast Cells | 1 | 2021 | 51 | 0.660 |
Why?
|
| Nerve Tissue Proteins | 4 | 2026 | 428 | 0.650 |
Why?
|
| Mitochondria | 1 | 2024 | 416 | 0.650 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 6 | 2020 | 142 | 0.640 |
Why?
|
| Transcriptional Activation | 4 | 2017 | 196 | 0.640 |
Why?
|
| Ion Channels | 1 | 2021 | 92 | 0.640 |
Why?
|
| Receptors, Purinergic P2X3 | 2 | 2018 | 5 | 0.640 |
Why?
|
| Ganglia, Spinal | 2 | 2018 | 30 | 0.630 |
Why?
|
| Mutation | 10 | 2024 | 2675 | 0.630 |
Why?
|
| Transcription, Genetic | 7 | 2018 | 911 | 0.620 |
Why?
|
| Superior Colliculi | 2 | 2010 | 12 | 0.610 |
Why?
|
| NADPH Oxidase 2 | 1 | 2019 | 36 | 0.600 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 3 | 2018 | 82 | 0.590 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 372 | 0.580 |
Why?
|
| Fear | 3 | 2026 | 71 | 0.580 |
Why?
|
| Gene Expression Regulation | 6 | 2021 | 1635 | 0.570 |
Why?
|
| Stress, Physiological | 1 | 2021 | 210 | 0.570 |
Why?
|
| Transcription Factors | 4 | 2021 | 1561 | 0.560 |
Why?
|
| Polycomb Repressive Complex 2 | 3 | 2020 | 17 | 0.560 |
Why?
|
| Signal Transduction | 7 | 2019 | 3170 | 0.550 |
Why?
|
| Synaptic Transmission | 6 | 2015 | 151 | 0.550 |
Why?
|
| Freund's Adjuvant | 1 | 2018 | 14 | 0.540 |
Why?
|
| Hyperalgesia | 1 | 2018 | 15 | 0.540 |
Why?
|
| Cell Differentiation | 7 | 2019 | 1391 | 0.540 |
Why?
|
| Epigenetic Repression | 1 | 2017 | 3 | 0.540 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 45 | 0.510 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 35 | 0.510 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2016 | 5 | 0.500 |
Why?
|
| Behavior, Animal | 2 | 2017 | 234 | 0.490 |
Why?
|
| Cognition | 2 | 2017 | 514 | 0.490 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2016 | 39 | 0.490 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2016 | 24 | 0.480 |
Why?
|
| Particulate Matter | 3 | 2025 | 72 | 0.480 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2013 | 22 | 0.480 |
Why?
|
| Humans | 35 | 2025 | 65831 | 0.470 |
Why?
|
| Serine Endopeptidases | 1 | 2016 | 125 | 0.470 |
Why?
|
| Culture Media, Conditioned | 4 | 2025 | 52 | 0.460 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2019 | 663 | 0.460 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 360 | 0.450 |
Why?
|
| Promoter Regions, Genetic | 6 | 2020 | 690 | 0.430 |
Why?
|
| Pyramidal Cells | 1 | 2014 | 27 | 0.410 |
Why?
|
| Polyphosphates | 2 | 2024 | 13 | 0.390 |
Why?
|
| Action Potentials | 2 | 2013 | 113 | 0.390 |
Why?
|
| Receptors, GABA-A | 2 | 2005 | 23 | 0.390 |
Why?
|
| TRPV Cation Channels | 1 | 2013 | 22 | 0.380 |
Why?
|
| Mice, Inbred C57BL | 10 | 2025 | 3506 | 0.380 |
Why?
|
| Patch-Clamp Techniques | 7 | 2015 | 137 | 0.380 |
Why?
|
| Sodium Channels | 1 | 2012 | 26 | 0.370 |
Why?
|
| Connexin 43 | 2 | 2023 | 14 | 0.370 |
Why?
|
| Glutamic Acid | 4 | 2022 | 105 | 0.360 |
Why?
|
| Mammals | 2 | 2024 | 222 | 0.350 |
Why?
|
| Chromatin | 4 | 2026 | 643 | 0.350 |
Why?
|
| Spinal Nerves | 2 | 2017 | 5 | 0.330 |
Why?
|
| Protein Subunits | 3 | 2014 | 169 | 0.330 |
Why?
|
| Transcriptome | 3 | 2020 | 408 | 0.320 |
Why?
|
| Pain | 1 | 2013 | 400 | 0.320 |
Why?
|
| Cell Death | 3 | 2024 | 289 | 0.310 |
Why?
|
| Brain Stem | 1 | 2008 | 30 | 0.280 |
Why?
|
| Genome-Wide Association Study | 2 | 2022 | 366 | 0.280 |
Why?
|
| Glycine | 2 | 2005 | 48 | 0.270 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 2 | 2020 | 17 | 0.260 |
Why?
|
| Brain | 4 | 2022 | 1672 | 0.260 |
Why?
|
| Nerve Net | 1 | 2008 | 105 | 0.260 |
Why?
|
| Carrier Proteins | 2 | 2016 | 719 | 0.250 |
Why?
|
| Green Fluorescent Proteins | 2 | 2026 | 372 | 0.230 |
Why?
|
| KCNQ2 Potassium Channel | 1 | 2025 | 4 | 0.230 |
Why?
|
| Receptors, GABA | 1 | 2025 | 13 | 0.230 |
Why?
|
| Up-Regulation | 4 | 2023 | 377 | 0.230 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2017 | 89 | 0.230 |
Why?
|
| Olfactory Bulb | 1 | 2025 | 19 | 0.230 |
Why?
|
| RNA Interference | 3 | 2020 | 647 | 0.220 |
Why?
|
| Gene Silencing | 3 | 2020 | 439 | 0.220 |
Why?
|
| Microtubules | 2 | 2003 | 210 | 0.220 |
Why?
|
| Animals, Newborn | 4 | 2017 | 241 | 0.220 |
Why?
|
| Neuroprotective Agents | 1 | 2025 | 80 | 0.220 |
Why?
|
| Cytoskeletal Proteins | 1 | 2026 | 204 | 0.210 |
Why?
|
| Gene Expression | 2 | 2020 | 856 | 0.200 |
Why?
|
| Male | 11 | 2025 | 31403 | 0.200 |
Why?
|
| Membrane Potentials | 3 | 2010 | 140 | 0.190 |
Why?
|
| Protein Binding | 3 | 2017 | 1638 | 0.180 |
Why?
|
| Basolateral Nuclear Complex | 1 | 2022 | 8 | 0.180 |
Why?
|
| MicroRNAs | 2 | 2020 | 714 | 0.180 |
Why?
|
| Neurotransmitter Agents | 1 | 2022 | 42 | 0.180 |
Why?
|
| Cell Line | 3 | 2021 | 2031 | 0.170 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 67 | 0.170 |
Why?
|
| Cytoskeleton | 1 | 2002 | 141 | 0.170 |
Why?
|
| Cell Degranulation | 1 | 2021 | 23 | 0.170 |
Why?
|
| Brain Injuries | 1 | 2023 | 141 | 0.170 |
Why?
|
| Acetylation | 2 | 2020 | 121 | 0.170 |
Why?
|
| Primary Cell Culture | 3 | 2017 | 80 | 0.160 |
Why?
|
| Interneurons | 1 | 2000 | 22 | 0.160 |
Why?
|
| Calcium | 3 | 2013 | 587 | 0.160 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2016 | 154 | 0.160 |
Why?
|
| Dentate Gyrus | 2 | 2016 | 12 | 0.150 |
Why?
|
| Dipeptides | 1 | 2020 | 69 | 0.150 |
Why?
|
| Down-Regulation | 1 | 2020 | 326 | 0.150 |
Why?
|
| Superoxides | 1 | 2019 | 73 | 0.150 |
Why?
|
| Phenotype | 3 | 2017 | 1236 | 0.140 |
Why?
|
| Cell Movement | 2 | 2019 | 484 | 0.140 |
Why?
|
| Osteogenesis | 2 | 2017 | 154 | 0.140 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 47 | 0.140 |
Why?
|
| Dependovirus | 1 | 2026 | 760 | 0.140 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2018 | 6 | 0.140 |
Why?
|
| Cell Lineage | 2 | 2017 | 282 | 0.140 |
Why?
|
| Histone Demethylases | 1 | 2018 | 30 | 0.140 |
Why?
|
| Circulating MicroRNA | 1 | 2017 | 6 | 0.130 |
Why?
|
| Histone Code | 1 | 2017 | 25 | 0.130 |
Why?
|
| DNA Damage | 1 | 2020 | 298 | 0.130 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2017 | 16 | 0.130 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2018 | 46 | 0.130 |
Why?
|
| Transfection | 2 | 2017 | 700 | 0.130 |
Why?
|
| Wharton Jelly | 1 | 2017 | 3 | 0.130 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2017 | 88 | 0.130 |
Why?
|
| Zinc Fingers | 1 | 2017 | 105 | 0.130 |
Why?
|
| Ethanol | 1 | 2000 | 333 | 0.130 |
Why?
|
| Dendritic Spines | 1 | 2016 | 12 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2016 | 503 | 0.120 |
Why?
|
| Glutathione Transferase | 1 | 2016 | 38 | 0.120 |
Why?
|
| Genes, Dominant | 1 | 2016 | 56 | 0.120 |
Why?
|
| Cytokines | 1 | 2021 | 965 | 0.120 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2008 | 77 | 0.120 |
Why?
|
| Gestational Age | 1 | 2017 | 196 | 0.120 |
Why?
|
| PC12 Cells | 2 | 2013 | 27 | 0.120 |
Why?
|
| Ozone | 1 | 2016 | 20 | 0.120 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 182 | 0.120 |
Why?
|
| Dendritic Cells | 1 | 2019 | 534 | 0.120 |
Why?
|
| Apolipoprotein E4 | 1 | 2016 | 48 | 0.120 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2016 | 6 | 0.120 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2016 | 15 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 129 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 198 | 0.120 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2015 | 19 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 269 | 0.110 |
Why?
|
| Stem Cells | 1 | 2017 | 278 | 0.110 |
Why?
|
| Long-Term Potentiation | 1 | 2015 | 42 | 0.110 |
Why?
|
| Ribosomal Proteins | 1 | 2015 | 42 | 0.110 |
Why?
|
| Muscle, Skeletal | 2 | 2018 | 789 | 0.110 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 238 | 0.110 |
Why?
|
| Receptors, AMPA | 2 | 2015 | 42 | 0.110 |
Why?
|
| Strychnine | 2 | 2007 | 4 | 0.100 |
Why?
|
| Autoantibodies | 1 | 2015 | 186 | 0.100 |
Why?
|
| Motor Activity | 1 | 2017 | 347 | 0.100 |
Why?
|
| Female | 10 | 2020 | 34420 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 206 | 0.100 |
Why?
|
| Myosin Type V | 1 | 2013 | 13 | 0.100 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2015 | 185 | 0.100 |
Why?
|
| Voltage-Gated Sodium Channel Blockers | 1 | 2013 | 4 | 0.100 |
Why?
|
| Neural Inhibition | 2 | 2004 | 30 | 0.100 |
Why?
|
| Trehalose | 1 | 2013 | 12 | 0.100 |
Why?
|
| Visual Cortex | 1 | 2013 | 29 | 0.100 |
Why?
|
| Myosin Heavy Chains | 1 | 2013 | 48 | 0.100 |
Why?
|
| Peptides | 1 | 2017 | 593 | 0.100 |
Why?
|
| Sodium | 1 | 2013 | 60 | 0.100 |
Why?
|
| Electric Stimulation | 2 | 2013 | 139 | 0.090 |
Why?
|
| DNA-Binding Proteins | 2 | 2015 | 1226 | 0.090 |
Why?
|
| In Vitro Techniques | 2 | 2013 | 491 | 0.090 |
Why?
|
| Calcium Signaling | 1 | 2013 | 168 | 0.090 |
Why?
|
| Pregnancy | 3 | 2020 | 2401 | 0.080 |
Why?
|
| Thy-1 Antigens | 2 | 2023 | 21 | 0.080 |
Why?
|
| Autophagy | 1 | 2013 | 240 | 0.080 |
Why?
|
| Gliosis | 2 | 2023 | 27 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 799 | 0.080 |
Why?
|
| Synaptic Potentials | 1 | 2010 | 6 | 0.080 |
Why?
|
| Aging | 1 | 2016 | 784 | 0.080 |
Why?
|
| Nuclear Matrix | 1 | 2010 | 28 | 0.080 |
Why?
|
| Calcitriol | 1 | 2010 | 25 | 0.080 |
Why?
|
| Receptors, Calcitriol | 1 | 2010 | 33 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 993 | 0.080 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2008 | 19 | 0.070 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2008 | 51 | 0.070 |
Why?
|
| Genetic Therapy | 1 | 2016 | 852 | 0.070 |
Why?
|
| Disease Progression | 1 | 2013 | 1229 | 0.070 |
Why?
|
| Mexico | 2 | 2020 | 39 | 0.070 |
Why?
|
| Cities | 2 | 2020 | 33 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2008 | 105 | 0.070 |
Why?
|
| Functional Laterality | 1 | 2008 | 141 | 0.070 |
Why?
|
| Fibrosis | 2 | 2018 | 172 | 0.060 |
Why?
|
| Glutathione | 1 | 2007 | 55 | 0.060 |
Why?
|
| Ascorbic Acid | 1 | 2007 | 53 | 0.060 |
Why?
|
| Glycine Agents | 2 | 2004 | 4 | 0.060 |
Why?
|
| Animals, Genetically Modified | 2 | 2017 | 312 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2007 | 216 | 0.060 |
Why?
|
| Antioxidants | 1 | 2007 | 252 | 0.050 |
Why?
|
| Nerve Degeneration | 1 | 2025 | 68 | 0.050 |
Why?
|
| Fetus | 1 | 2005 | 103 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2007 | 323 | 0.050 |
Why?
|
| Presynaptic Terminals | 1 | 2004 | 38 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 859 | 0.050 |
Why?
|
| Serine | 2 | 2022 | 90 | 0.050 |
Why?
|
| Embryo, Mammalian | 2 | 2016 | 158 | 0.050 |
Why?
|
| Integrin alpha5 | 1 | 2023 | 7 | 0.050 |
Why?
|
| Integrin beta3 | 1 | 2023 | 8 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2023 | 963 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2023 | 178 | 0.050 |
Why?
|
| Ion Transport | 1 | 2002 | 19 | 0.040 |
Why?
|
| Colchicine | 1 | 2002 | 29 | 0.040 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2002 | 39 | 0.040 |
Why?
|
| Biomarkers | 2 | 2017 | 1502 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2023 | 216 | 0.040 |
Why?
|
| Oxidation-Reduction | 2 | 2016 | 328 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2023 | 301 | 0.040 |
Why?
|
| Binding Sites | 3 | 2012 | 922 | 0.040 |
Why?
|
| Picrotoxin | 1 | 2000 | 5 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2020 | 96 | 0.040 |
Why?
|
| Chile | 1 | 2020 | 14 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2020 | 146 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 211 | 0.040 |
Why?
|
| Zinc | 1 | 2000 | 95 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 542 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2020 | 611 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2020 | 401 | 0.040 |
Why?
|
| Adult Stem Cells | 1 | 2019 | 30 | 0.040 |
Why?
|
| Mice, Inbred mdx | 1 | 2018 | 17 | 0.040 |
Why?
|
| Cell Survival | 2 | 2013 | 588 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2018 | 111 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2020 | 617 | 0.030 |
Why?
|
| Child | 2 | 2020 | 4651 | 0.030 |
Why?
|
| Neuromuscular Junction | 1 | 2018 | 83 | 0.030 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2017 | 9 | 0.030 |
Why?
|
| Locomotion | 1 | 2018 | 111 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 1997 | 34 | 0.030 |
Why?
|
| Sp7 Transcription Factor | 1 | 2017 | 4 | 0.030 |
Why?
|
| Rotarod Performance Test | 1 | 2017 | 3 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 4882 | 0.030 |
Why?
|
| Atrophy | 1 | 2017 | 89 | 0.030 |
Why?
|
| Methylation | 1 | 2017 | 130 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2017 | 184 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 220 | 0.030 |
Why?
|
| Wechsler Scales | 1 | 2016 | 16 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2016 | 7 | 0.030 |
Why?
|
| Wound Healing | 1 | 2017 | 193 | 0.030 |
Why?
|
| Adipogenesis | 1 | 2017 | 81 | 0.030 |
Why?
|
| Neurites | 1 | 2016 | 23 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 148 | 0.030 |
Why?
|
| Inflammation | 1 | 2023 | 1198 | 0.030 |
Why?
|
| Electromyography | 1 | 2016 | 100 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 53 | 0.030 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2015 | 4 | 0.030 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2015 | 9 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2016 | 184 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2015 | 46 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2015 | 48 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 1997 | 351 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 605 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 2015 | 199 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 2016 | 228 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2012 | 710 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2016 | 502 | 0.020 |
Why?
|
| Excitatory Amino Acid Agents | 1 | 2013 | 6 | 0.020 |
Why?
|
| Guanylate Kinases | 1 | 2013 | 8 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2013 | 18 | 0.020 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2013 | 17 | 0.020 |
Why?
|
| Synaptosomes | 1 | 2013 | 16 | 0.020 |
Why?
|
| Biophysics | 1 | 2013 | 42 | 0.020 |
Why?
|
| Electroporation | 1 | 2013 | 36 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2013 | 103 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 128 | 0.020 |
Why?
|
| Neuroglia | 1 | 2013 | 81 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 301 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 132 | 0.020 |
Why?
|
| Zebrafish | 1 | 2016 | 374 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2016 | 901 | 0.020 |
Why?
|
| Longevity | 1 | 2013 | 118 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2012 | 252 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2016 | 2168 | 0.020 |
Why?
|
| Mediator Complex Subunit 1 | 1 | 2010 | 7 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 3777 | 0.020 |
Why?
|
| Adult | 2 | 2017 | 17575 | 0.020 |
Why?
|
| Ligands | 1 | 2010 | 414 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 672 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2010 | 242 | 0.020 |
Why?
|
| Oxidants | 1 | 2007 | 18 | 0.020 |
Why?
|
| Respiratory Burst | 1 | 2007 | 21 | 0.020 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2007 | 5 | 0.020 |
Why?
|
| Bicuculline | 1 | 2007 | 6 | 0.020 |
Why?
|
| Receptor, trkB | 1 | 2007 | 7 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2007 | 83 | 0.020 |
Why?
|
| Oxidoreductases | 1 | 2007 | 61 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2007 | 34 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 1573 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 6367 | 0.010 |
Why?
|
| DNA | 1 | 2010 | 853 | 0.010 |
Why?
|
| Receptor Aggregation | 1 | 2004 | 5 | 0.010 |
Why?
|
| Homeostasis | 1 | 2007 | 383 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 15145 | 0.010 |
Why?
|
| Interferon Regulatory Factor-2 | 1 | 1997 | 5 | 0.010 |
Why?
|
| Casein Kinase II | 1 | 1997 | 16 | 0.010 |
Why?
|
| COS Cells | 1 | 1997 | 180 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1997 | 102 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1997 | 94 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 1997 | 224 | 0.010 |
Why?
|